Community
GlycoNet receives government funding to encourage confidence in vaccines across the country
The grant will help deliver reliable vaccine information to help Canadians make evidence-based decisions on vaccines.
GlycoNet joins national industry association to drive economic growth in the biotechnology sector
As a member of BIOTECanada’s network, GlycoNet aims to mobilize glycomics research into tangible and sustainable innovation for Canadians.
Innovative coating for blood vessels reduces rejection of transplanted organs
Knowledge in the sugars that coat blood vessels helps researchers find a way to reduce organ rejection.
More stories
- All
- Awards
- Community
- Network Profile
- Press Release
- Research Highlight
Solving blood supply shortage with glycomics
GlycoNet Investigators study the sugars on red blood cells to find ways to make universal donor blood
GlycoNet start-up listed as top 10 therapeutics start-ups and companies in Edmonton
48Hour Discovery shows exceptional innovation, growth, management, and societal impact, according to BestStartup.
GlycoNet Investigator develops new chemistry to facilitate drug development and manufacturing
The collaborative project is partnered with CQDM, Simon Fraser University, Amgen, Merck, and Servier.
Carbohydrate ‘cage’ allows precise drug delivery to inflammation site in the gastrointestinal tract
A GlycoCage technology developed by GlycoNet researchers aims to improve current treatments for inflammatory bowel disease
Pooling Canadian innovation efforts to make breakthrough discoveries
Scientific collaboration yields new hope for children affected by rare blood disorder
GlycoNet Investigator meets the Parliamentary Health Research Caucus to present glycomics research
Dr. Yves St-Pierre shared how glycomics could help develop a new-generation cancer immunotherapy.
GlycoNet announces 15 projects awarded as part of its Glycomics Training Program
Trainees will receive support and resources while advancing glycomics research in areas such as antimicrobials, drug discovery, immune response, cancer, and neurodegenerative diseases
GlycoNet Investigator received McGill’s Principal’s Prize for Public Engagement Through Media
From offering policy advice to sharing his expertise on COVID-19 with the media and public, Dr. Donald Sheppard is recognized a role model with his achievement in engaging with the broader community
GlycoNet and BridgeBio Pharma Inc. initiate collaboration to discover potential treatments for genetic diseases through glycomics research
Genetic disease research has benefitted substantially from the study of glycomics, which relates to the functions of glycans, or sugar, in biological systems
Canadian Glycomics Network
E5-33 Gunning/Lemieux Chemistry Centre
University of Alberta, T6G 2G2
Tel: 780-492-6204
Fax: 780-492-4147
Subscribe to GlycoNet’s Newsletter
© CANADIAN GLYCOMICS NETWORK (GLYCONET). ALL RIGHTS RESERVED.
English 
French